Cleared Traditional

K130263 - STERRAD 50/100S/200 TEST PACK

K130263 is the FDA 510(k) clearance for STERRAD 50/100S/200 TEST PACK by Advanced Sterilization Products. It is a Class 2 General Hospital device (product code FRC) cleared through the Traditional 510(k) pathway after a 417-day FDA review.

K130263 · Advanced Sterilization Products · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2014
Decision
417d
Days
Class 2
Risk

K130263 is an FDA 510(k) clearance for the STERRAD 50/100S/200 TEST PACK. Classified as Indicator, Biological Sterilization Process (product code FRC), Class II - Special Controls.

Submitted by Advanced Sterilization Products (Irvin, US). The FDA issued a Cleared decision on March 28, 2014 after a review of 417 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.2800 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Advanced Sterilization Products devices

Submission Details

510(k) Number K130263 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 04, 2013
Decision Date March 28, 2014
Days to Decision 417 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
288d slower than avg
Panel avg: 129d · This submission: 417d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FRC Indicator, Biological Sterilization Process
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.2800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FRC Indicator, Biological Sterilization Process

All 107
Devices cleared under the same product code (FRC) and FDA review panel - the closest regulatory comparables to K130263.
3M ATTEST RAPID READOUT BIOLOGICAL INDICATOR / 3M ATTEST AUTO-READER
K140392 · 3M Company · Aug 2014
VERIFY V24 SELF-CONTAINED BIOLOGICAL INDICATOR FOR VAPORIZED VH202 STERILIZATION PROCESSES
K140499 · STERIS Corporation · Jul 2014
VERIFY V24 SELF-CONTAINED BIOLOGICAL INDICATOR
K140708 · STERIS Corporation · Jun 2014
3M ATTEST(TM) AUTO-READER
K123546 · 3M Company · Mar 2013
3M ATTEST (TM) SUPER RADID READOUT STEAM CHALLENGE PACK 3M ATTEST(TM) SUPER RAPID 5 STEAM-PLUS CHALLENGE PACK
K121593 · 3M Company · Mar 2013
STERRAD CYCLESURE 24 BIOLOGICAL INDICATOR MODEL 14324
K123017 · Advanced Sterilization Products · Dec 2012